Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATYR | AZN | AMGN | GILD | VRTX |
| Company | Atyr Pharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7699 | 90.65 | 344.23 | 124.81 | 462.00 |
| High | 0.8596 | 90.87 | 346.33 | 124.96 | 463.70 |
| Low | 0.7524 | 89.77 | 338.94 | 122.40 | 453.54 |
| Latest | 0.8278 | 90.03 | 340.16 | 122.62 | 457.36 |
| Change | +0.0570 | -0.82 | -5.26 | -2.38 | -5.77 |
| % Change | +7.39% | -0.90% | -1.52% | -1.90% | -1.25% |
| Volume | 3,228,200 | 5,250,800 | 3,695,800 | 5,234,200 | 1,518,900 |
| 20-Day Average Volume | 3,442,805 | 5,525,600 | 2,905,470 | 6,931,200 | 1,434,730 |
| Previous Close | 0.7708 | 90.85 | 345.42 | 125.00 | 463.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7431 | 89.51 | 336.77 | 124.46 | 431.02 |
| 20-Day Raw Stochastic | 85.52% | 62.56% | 81.63% | 47.45% | 88.65% |
| 20-Day Relative Strength | 40.90 | 58.86 | 61.86 | 50.56 | 64.10 |
| Weighted Alpha | -12.33 | +36.51 | +28.98 | +31.19 | +3.49 |
| Today's Opinion | 88% Sell | 100% Buy | 100% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 56% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.18% since 11/26/25 | -3.53% since 11/26/25 | -1.28% since 11/26/25 | -3.83% since 11/26/25 | +5.83% since 11/26/25 |
| Low | 0.7001 on 12/03/25 | 89.77 on 12/04/25 | 336.25 on 12/01/25 | 122.40 on 12/04/25 | 423.45 on 12/01/25 |
| High | 0.8596 on 12/04/25 | 92.98 on 12/01/25 | 346.38 on 12/03/25 | 127.80 on 11/28/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +0.15% since 11/04/25 | +9.75% since 11/04/25 | +14.65% since 11/04/25 | -0.31% since 11/04/25 | +8.46% since 11/04/25 |
| Low | 0.6400 on 11/21/25 | 81.02 on 11/05/25 | 302.13 on 11/05/25 | 117.13 on 11/10/25 | 406.67 on 11/07/25 |
| High | 0.8596 on 12/04/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -84.87% since 09/04/25 | +10.09% since 09/04/25 | +21.44% since 09/04/25 | +8.73% since 09/04/25 | +15.22% since 09/04/25 |
| Low | 0.6400 on 11/21/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 6.5000 on 09/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -83.89% since 06/04/25 | +23.33% since 06/04/25 | +18.52% since 06/04/25 | +12.47% since 06/04/25 | +2.58% since 06/04/25 |
| Low | 0.6400 on 11/21/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 7.2904 on 07/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 81,114 | 279,221,376 | 183,169,696 | 152,132,192 | 116,040,920 |
| Shares Outstanding, K | 97,987 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 240,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -64,020,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 190,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -25,740,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.57 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/06/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.88 | 15.79 | 15.26 | 30.25 |